BioLargo (BLGO) President acquires 130,222 shares under lock-up terms
Rhea-AI Filing Summary
BioLargo, Inc. director and President received additional common stock as compensation. On 12/31/2025, the reporting person acquired 130,222 shares of BioLargo common stock at $0.1843 per share, in exchange for a reduction of salary and unreimbursed business expenses. After this transaction, the reporting person beneficially owned 10,523,625 shares of BioLargo common stock, held directly, which includes shares held through a limited liability company that the reporting person owns and controls. The newly issued shares are subject to a lock-up agreement and cannot be sold until BioLargo reports at least $40 million in gross revenue for any reported period, or its market capitalization exceeds $300 million, or there is a change in control of the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 130,222 | $0.1843 | $24K |
Footnotes (1)
- The shares issued are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer. Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares issued and the acquisition price per share). Includes 1,528,695 shares owned indirectly by Reporting Person through a limited liability company owned and controlled by Reporting Person.